Gravar-mail: Moclobemide and the Risk of Serotonin Toxicity (or Serotonin Syndrome): Comment to the manuscript by Udo Bonnet, Moclobemide: Therapeutic Use and Clinical Studies. CNS Drug Reviews 2003;9:97–140.